Related Experiment Video
Updated: Nov 10, 2025

14:53
A Microfluidic-based Electrochemical Biochip for Label-free DNA Hybridization Analysis
Published on: September 10, 2014
17.5K
Microfluidic Impedance Biosensor Chips Using Sensing Layers Based on DNA-Based Self-Assembled Monolayers for
Khaled Alsabbagh1, Tim Hornung1, Achim Voigt1
1Institute of Microstructure Technology, Karlsruhe Institute of Technology, Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-Leopoldshafen, Germany.
Biosensors
|April 3, 2021
Summary
This study introduces a novel microfluidic biosensor for label-free protein detection. The device demonstrates sensitive detection of cardiac troponin I, a key biomarker for heart attacks, using electrochemical impedance spectroscopy.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Nanotechnology
Background:
- Cardiac troponin I (cTnI) is a critical biomarker for diagnosing myocardial infarction.
- Current diagnostic methods can be time-consuming or require complex sample preparation.
- Label-free biosensing offers a promising alternative for rapid and sensitive biomarker detection.
Purpose of the Study:
- To develop and validate a microfluidic chip for electrochemical impedance spectroscopy (EIS) based biosensing.
- To achieve label-free detection of cardiac troponin I (cTnI) for potential myocardial infarction diagnosis.
- To optimize electrode surface functionalization for enhanced sensitivity and specificity.
Main Methods:
- Fabrication of a microfluidic chip integrating sputtered electrodes on a glass slide and a polydimethylsiloxane (PDMS) microchannel.
- Development of electrode functionalization protocols using self-assembled monolayers (SAMs) of thiolated oligonucleotides and covalent antibody coupling via carbodiimide chemistry.
- Electrochemical impedance spectroscopy (EIS) measurements for label-free protein detection, including human serum albumin (HSA) as a control and cTnI as the target analyte.
Main Results:
- Oligonucleotide-based SAMs demonstrated superior performance compared to hydrocarbon SAMs for electrode functionalization.
- The microfluidic impedance biosensor successfully detected low concentrations of cardiac troponin I (1 ng/mL) with significant impedance shifts.
- Negligible impedance changes were observed for human serum albumin (1000 ng/mL), indicating high specificity.
Conclusions:
- The developed microfluidic impedance biosensor chip enables rapid, label-free detection of cardiac troponin I.
- The sensor shows promise for clinical applications in diagnosing myocardial infarction by detecting relevant biomarker concentrations.
- Further development could lead to point-of-care diagnostic tools for cardiovascular diseases.
Keywords:
biosensorcardiac troponin Ielectrochemical impedance spectroscopyimmunosensorlabel-freemicrofluidic chipproteinsself-assembled monolayerssingle-strand DNA
